about
Predictors of first-fill adherence for patients with hypertensionPsychosocial risk factors for hypertension: an update of the literatureSimulated Conversations With Virtual Humans to Improve Patient-Provider Communication and Reduce Unnecessary Prescriptions for Antibiotics: A Repeated Measure Pilot Study.Does improving patient-practitioner communication improve clinical outcomes in patients with cardiovascular diseases? A systematic review of the evidenceCounseling African Americans to Control Hypertension (CAATCH) trial: a multi-level intervention to improve blood pressure control in hypertensive blacks.Patient-physician racial/ethnic concordance and blood pressure control: the role of trust and medication adherence.Community-based settings and sampling strategies: implications for reducing racial health disparities among black men, New York City, 2010-2013.Secondary analysis of electronically monitored medication adherence data for a cohort of hypertensive African-AmericansDeveloping a toolkit for panel management: improving hypertension and smoking cessation outcomes in primary care at the VA.Center for stroke disparities solutions community- based care transition interventions: study protocol of a randomized controlled trial.A practice-based trial of blood pressure control in African Americans (TLC-Clinic): study protocol for a randomized controlled trial.Panel Management to Improve Smoking and Hypertension Outcomes by VA Primary Care Teams: A Cluster-Randomized Controlled Trial.Correlates of Adherence to Varenicline Among HIV+ Smokers.Medication Routines and Adherence Among Hypertensive African Americans.The FAITH Trial: Baseline Characteristics of a Church-based Trial to Improve Blood Pressure Control in Blacks.A systematic review of the effects of home blood pressure monitoring on medication adherence.Rates and Predictors of Uncontrolled Hypertension Among Hypertensive Homeless Adults Using New York City Shelter-Based Clinics.Appointment-keeping behavior is not related to medication adherence in hypertensive African Americans.Comparative Effectiveness of a Practice-Based Comprehensive Lifestyle Intervention vs. Single Session Counseling in Hypertensive Blacks.The effect of patient-provider communication on medication adherence in hypertensive black patients: does race concordance matter?A practice-based trial of motivational interviewing and adherence in hypertensive African Americans.Provider communication effects medication adherence in hypertensive African Americans.Racism and hypertension: a review of the empirical evidence and implications for clinical practice.Overcoming barriers to hypertension control in African Americans.Obesity interventions in African American faith-based organizations: a systematic review.Perceived discrimination and medication adherence in black hypertensive patients: the role of stress and depression.Addressing the Social Needs of Hypertensive Patients: The Role of Patient-Provider Communication as a Predictor of Medication Adherence.Daily interpersonal conflict predicts masked hypertension in an urban sample.Rationale and design of the Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial.A practice-based randomized controlled trial to improve medication adherence among Latinos with hypertension: study protocol for a randomized controlled trial.Patient factors, but not provider and health care system factors, predict medication adherence in hypertensive black men.Rationale and design of Faith-based Approaches in the Treatment of Hypertension (FAITH), a lifestyle intervention targeting blood pressure control among black church members.An RCT of the effect of motivational interviewing on medication adherence in hypertensive African Americans: rationale and design.Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans.A senior center-based pilot trial of the effect of lifestyle intervention on blood pressure in minority elderly people with hypertension.Reexamining medication adherence in black patients with hypertension through the lens of the social determinants of health.Perceived racial discrimination and adoption of health behaviors in hypertensive Black Americans: the CAATCH trial.It takes two to tango: A dyadic approach to understanding the medication dialogue in patient-provider relationships.Cardiovascular health in Hispanics/Latinos: a reexamination of the Hispanic paradox.Combining Text Messaging and Telephone Counseling to Increase Varenicline Adherence and Smoking Abstinence Among Cigarette Smokers Living with HIV: A Randomized Controlled Study.
P50
Q24648910-29EBB637-3D70-4578-B115-5BB8AD9CC80FQ28394330-7E5CE5B4-A1C8-4AA8-84C3-F9AE216C1C8BQ30148713-D8D18459-FF6F-42DF-B74F-CE8AF3B4F079Q30583452-6E0191F6-A79F-4478-BA3F-98224B49F62DQ33567542-1F88C136-7AF7-4503-93FB-5CEFE888A92DQ33651171-B5B533E1-60ED-424C-965D-F0213E3CB1A6Q33796904-2B9D5301-A5F9-4E96-BB93-447CB89728C2Q34246845-E5EF0AD7-227D-47F6-BFFA-562E609B7794Q35049751-83827E5C-3AA3-49D4-8785-B6EA8DB012C5Q35066058-E0D698C6-F3A6-4B06-917C-35D6E03C07E6Q35690096-7756BB62-E6B1-45EE-BAEF-5DAC28C000B1Q35752668-1C03BE91-83D7-45F4-99C7-695268E0E4B4Q36087171-169267DF-2716-42E6-978F-C9C6789879FDQ36302293-67D2A423-7B7E-494D-8753-589778B82AA3Q36351360-C9B08D71-17E6-4105-9A17-9B91AB8B8B8AQ36416105-6A2A5963-8FE3-48B9-849A-3E2A2C809851Q36452120-46B49B5C-8959-4FAC-B64E-81E2A5D5491AQ36552030-E7398541-E9AE-4850-BEA6-1AD70BFFF758Q36573638-147CE653-8F02-43E4-BD92-C612B72C7EFCQ36881937-13DA9A00-D80B-4176-93A1-4D9162F1D444Q37105768-170A25EE-8504-4F73-9C83-252B65064EFAQ37231537-0E2DC66B-07EB-4C69-9E8C-019DB48EA273Q37844400-E6DACF67-59A9-4100-AF5F-182CA981F374Q37973304-AEE36A0E-1586-4F08-80D5-E63550007CD6Q38246702-07A13CF5-E33C-4DE3-A251-D59D444A44AEQ38433464-B6732281-FD71-46C1-BF16-850A9DF89F9EQ38613427-07BE88B6-3A01-46E6-AD75-BEE16FD8D358Q39940991-0179F5E3-46FC-4BB8-8F8E-761915F5DAE2Q40524456-612AB3AD-7D63-4398-A0B8-F186890780EBQ40775839-940657D8-79EE-437D-ADE4-DB177D51B8F0Q43496299-7A6CD463-6720-4A94-A4B8-3DD779E05A99Q44726600-FD597AF3-CC5C-4DB2-AF6F-7B6EFE455746Q46207390-788BC122-0174-4C9B-B7CC-C998FC231C5EQ46424031-449C1F14-E09C-4FAA-AF86-04772CD074F4Q46600641-87CA6605-59BC-4DD6-9B5A-0EDEF9D0526EQ47681312-3072979B-79F7-48B5-8F58-52F33FE9D99BQ50724350-CC7AD364-764B-48A6-BAE1-942A3311362CQ52686234-B0B75502-BE85-4AEF-A225-5FDB5CD3491DQ53675241-1B7F8473-2029-4405-A2E7-58C81DF6B1A8Q54526842-22958F53-7A48-4461-9B91-E9D0925B8BC2
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antoinette M Schoenthaler
@ast
Antoinette M Schoenthaler
@en
Antoinette M Schoenthaler
@es
Antoinette M Schoenthaler
@nl
type
label
Antoinette M Schoenthaler
@ast
Antoinette M Schoenthaler
@en
Antoinette M Schoenthaler
@es
Antoinette M Schoenthaler
@nl
prefLabel
Antoinette M Schoenthaler
@ast
Antoinette M Schoenthaler
@en
Antoinette M Schoenthaler
@es
Antoinette M Schoenthaler
@nl
P106
P21
P31
P496
0000-0003-4905-5136